Related Experiment Video
Updated: Aug 19, 2025

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
ACR Appropriateness Criteria® Suspected Pulmonary Hypertension: 2022 Update.
, Arlene Sirajuddin1, S Mojdeh Mirmomen2
1National Institutes of Health, Bethesda, Maryland.
Diagnosing pulmonary hypertension involves various imaging tests. These imaging examinations help identify the cause of pulmonary hypertension, guiding treatment strategies.
Area of Science:
- Radiology
- Cardiology
- Pulmonology
Background:
- Pulmonary hypertension (PH) can be idiopathic or secondary to various conditions.
- Accurate diagnosis and etiological determination are crucial for effective PH management.
Framework:
- The American College of Radiology (ACR) Appropriateness Criteria provide evidence-based guidelines for clinical conditions.
- These guidelines are developed and updated annually by a multidisciplinary expert panel.
- Methodologies like Grading of Recommendations Assessment, Development, and Evaluation (GRADE) and the RAND/UCLA Appropriateness Method are employed.
Implementation:
- This document reviews key imaging examinations for PH diagnosis and etiology.
- Imaging modalities discussed include chest radiography, echocardiography, V/Q scintigraphy, CT, MRI, right heart catheterization, and pulmonary angiography.
- The ACR criteria guide the selection of appropriate imaging procedures for specific clinical scenarios.
Implications:
- Appropriate use of imaging examinations can lead to timely and accurate diagnosis of pulmonary hypertension.
- Understanding the etiology of PH through imaging facilitates targeted treatment.
- These evidence-based guidelines support clinicians in optimizing diagnostic pathways for PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

